Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Volt Pharma Associates

VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

Volt Pharma Associates
Engesserstrasse 4B, Freiburg, 79114, Germany
+49 172 6340202
Contact Volt Pharma Associates
Website

 Latest Content from PMHub 

Onyx Health Launch National Competition for Life Science SMEs

Press Releases | January 27, 2021 | Onyx Health

Healthcare marketing communications agency Onyx Health are launching a national competition #ThinkBig to help health and life sciences SMEs bounce back from the COVID-19 crisis

What does the future hold for Medical Affairs?

White Papers and Resources | January 27, 2021 | Blue Latitude Health

Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.

Wilmington Healthcare appoints new Head of Digital

Press Releases | January 26, 2021 | Wilmington Healthcare

Wilmington Healthcare, which provides data, insight and intelligence for pharma and medtech companies, has appointed Pfizer’s former UK Digital Marketing Manager, Mikko Figura, as Head of Digital.In his new role,...

Mistrust in medical research: a patient perspective

White Papers and Resources | January 22, 2021 | Blue Latitude Health

The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...

Real-world evidence: breaking boundaries in rare disease

White Papers and Resources | January 22, 2021 | Blue Latitude Health

Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

The heavy toll of COVID-19 on cancer patients

White Papers and Resources | January 22, 2021 | Blue Latitude Health

We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Unpacking rare diseases in the first edition of Delta magazine

White Papers and Resources | January 22, 2021 | Blue Latitude Health

Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization

Virtual HealthTech conference powered by Impetus Digital: A Customer Story

White Papers and Resources | January 22, 2021 | Impetus Digital

In this customer story, we summarize one of the pilot projects conducted using our new and award-winning platform: InSite Event™.

Future-Proofing Healthcare and Medicine

Videos and Podcasts | January 21, 2021 | Impetus Digital

Bogi Eliasen, Director of Health at Copenhagen Institute for Futures Studies, discusses the future of genomics, personalized health, healthcare data, digital health, and more.

AI in Computer Vision Technology and the Impact on Healthcare

Videos and Podcasts | January 21, 2021 | Impetus Digital

Moshe Safran, CEO at RSIP Vision USA, delves into a range of topics around computer vision, AI, and deep learning in medical imaging, surgery, and healthcare, including the work that...